BCIFlex
Health Tech & Medtech · Guangzhou, China · Founded 2022
AI-powered brain-computer interfaces for medical research applications MoreLess
BCIFlex is a life sciences company, founded in 2022 and headquartered in Beijing, China, that specializes in the development of brain-computer interfaces for the medical industry. The firm develops artificial intelligence application system integration services aimed at enhancing the efficiency of medical research and experimental development for its users. Its products include implantable stretchable flexible neural electrodes.
The company's intellectual property includes patents for a flexible neural electrode composite structure and its manufacturing and implantation methods, which are designed to improve operational flexibility and post-implantation stability. In 2025, BCIFlex secured over RMB 300 million (approximately USD 42 million) in a Series A funding round. The round was co-led by a fund managed by Legend Capital Management and IDG Capital, with participation from investors such as Yuanbio Venture Capital, China Life Capital, Lenovo Capital, Meituan's DragonBall Capital, and Baidu Venture.
Keywords: brain-computer interfaces, medical technology, life sciences, artificial intelligence, medical research, neural electrodes, therapeutic devices, neurotechnology, system integration, medical devices, flexible electronics, biomedical engineering, AI in healthcare, neurostimulation, implantable devices, Beijing startup, health tech, electrophysiology, medical innovation, biosensors
Company overview
BCIFlex company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2022
- Headquarters
- Guangzhou, China
- Employees
- —
- Open positions
- None listed
- Dealroom signal
- 18.7
Valuation & funding
BCIFlex funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Aug 2025 | $42M | $168M | China Life Investment Management · Legend Capital · YuanBio Venture Capital | ↗ |
Comparisons
BCIFlex compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
BCIFlex's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where BCIFlex has talent and traffic
In the news
Latest news about BCIFlex
Recent press, funding announcements, and product moves mentioning BCIFlex — open to read from the original sources.
Market sentiment
What the market is saying about BCIFlex
An AI-synthesized read of the highest-engagement posts about BCIFlex on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BCIFlex’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









